Biomarker Conservation in Primary and Metastatic Epithelial Ovarian Cancer
Data up to Jan 2025
Total Citations Per Year
Abstract
References (30)
The Clonal Evolution of Tumor Cell Populations
1976 • 6,310 citations
A mathematic model for relating the drug sensitivity of tumors to their spontaneous mutation rate.
1979 • 1,331 citations
Chromosome Studies on Normal and Leukemic Human Leukocytes
1960 • 1,051 citations
Zur Frage der Entstehung maligner Tumoren
1914 • 796 citations
X‐CHROMOSOME INACTIVATION AND DEVELOPMENTAL PATTERNS IN MAMMALS
1972 • 657 citations
Rationale for the use of alternating non-cross-resistant chemotherapy.
1982 • 545 citations
Tumor angiogenesis in advanced stage ovarian carcinoma.
1995 • 395 citations
Vascular permeability factor gene expression in normal and neoplastic human ovaries.
1994 • 259 citations
Prognostic factors in ovarian cancer.
1991 • 192 citations
Clonal Origin of Epithelial Ovarian Carcinoma: Analysis by Loss of Heterozygosity, p53 Mutation, and X-Chromosome Inactivation
1992 • 157 citations
Prognostic and predictive value of tumour angiogenesis in ovarian carcinomas
1996 • 132 citations
The Expression of Vascular Endothelial Growth Factor and Transforming Growth Factor-β Associates With Angiogenesis in Epithelial Ovarian Cancer
1997 • 102 citations
Prognostic factors in ovarian cancer
1998 • 87 citations
Immunophenotype of Ovarian Cancer as Predictor of Clinical Outcome: Evaluation at Primary Surgery and Second-Look Procedure
1998 • 63 citations
The molecular basis of ovarian cancer
1995 • 57 citations
Flow cytometric analysis of lymph node metastases in advanced ovarian cancer: Clinical and biologic significance
1997 • 34 citations
Overexpression and relationships of HER-2/neu, epidermal growth factor receptor, p53, Ki-67, and tumor necrosis factor alpha in epithelial ovarian cancer.
1996 • 33 citations
Ovarian carcinoma heterogeneity as demonstrated by DNA ploidy
1993 • 32 citations
Molecular genetic evidence for unifocal origin of advanced epithelial ovarian cancer and for minor clonal divergence
1995 • 32 citations
DNA Index Reflects the Biological Behavior of Ovarian Carcinoma Stage I–IIa
1996 • 32 citations
Tumor heterogeneity and in vitro chemosensitivity testing in ovarian cancer
1997 • 30 citations
The Genetic Basis of Resistance to Cancer Chemotherapy
1995 • 30 citations
Flow cytometric DNA ploidy and S-phase heterogeneity in advanced ovarian carcinoma
1994 • 21 citations
Elevated Serum ICTP Concentrations Reflect Poor Prognosis in Patients with Ovarian Carcinoma
1995 • 16 citations
p53 expression, DNA content and cell proliferation in primary and synchronous metastatic lesions from ovarian surface epithelial-stromal tumours
1996 • 9 citations
Concordance of DNA Ploidy Pattern as Measured by Flow Cytometry in Primary, Metastatic, and Persistent Ovarian Carcinoma
1996 • 5 citations
Detection of Cellular Heterogeneity by DNA Ploidy, 17 Chromosome, and p53 Gene in Primary Carcinoma and Metastasis in a Case of Ovarian Cancer
1996 • 5 citations
Intratumor heterogeneity of morphometric and stereologic variables in primary ovarian tumors and their omental metastatic deposits.
1997 • 3 citations
Chemotherapy changes the DNA ploidy in ovarian cancer
1995 • 2 citations
Minimizing drug resistance. The somatic mutation model and gestational trophoblastic neoplasia.
1987 • 2 citations